BioCentury
ARTICLE | Company News

Asahi Kasei Pharma, RaQualia deal

April 4, 2016 7:00 AM UTC

Asahi and RaQualia partnered to discover pain compounds targeting an undisclosed ion channel. The partners will use RaQualia’s drug development technology. RaQualia will receive an undisclosed researc...